| 标题 |
Minimal residual disease monitoring by quantitative RT‑PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML‑15 trial |
| 网址 | |
| DOI |
10.1182/blood‑2012‑06‑435669
doi
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)